Skip to content

Clinical trials

Phase 3 Purpura, Thrombocytopenic, Idiopathic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 3 Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20111
20121
20151
20161
20191
20204
20212
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx4
Novartis Pharmaceuticals3
GlaxoSmithKline2
UCB Biopharma SRL2
Biotest1
CSL Behring1
Kedrion S.p.A.1
Octapharma1
Principia Biopharma, a Sanofi Company1
Rigel Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic19
Thrombocytopenia4
Purpura2
Autoimmune Diseases1
Blood Coagulation Disorders1
Blood Platelet Disorders1
Hematologic Diseases1
Hemorrhagic Disorders1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.